Volume 11, Number 5—May 2005
THEME ISSUE
Dengue and Dengue Hemorrhagic Fever
Dengue and Dengue Hemorrhagic Fever
Dengue Antibody Prevalence in German Travelers
Ole Wichmann*
, Annekathrin Lauschke*, Christina Frank†, Pei-Yun Shu‡, Matthias Niedrig†, Jyh-Hsiung Huang‡, Klaus Stark†, and Tomas Jelinek*
, Annekathrin Lauschke*, Christina Frank†, Pei-Yun Shu‡, Matthias Niedrig†, Jyh-Hsiung Huang‡, Klaus Stark†, and Tomas Jelinek*
Table 1
Prevalence of anti-dengue antibodies in 2,255 patients according to travel destination and time*
| Years | No. acute infections/total no. travelers (%) |
||
|---|---|---|---|
| Southeast Asia and Indian subcontinent | Sub-Saharan Africa | Latin America and the Caribbean | |
| 1996–1998 | 22/491 (4.5) | 2/309 (0.6) | 4/271 (1.5) |
| 2002–2004 | 25/529 (4.7) | 3/376 (0.8) | 8/279 (2.9) |
| Total | 47/1,020 (4.6) | 5/685 (0.7) | 12/550 (2.2) |
*Four patients are not included in this analysis since they traveled to >1 continent.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.